1 244

Cited 12 times in

Subcellular localization of Mdm2 expression and prognosis of breast cancer

Authors
 Hyung Seok Park  ;  Ji Min Park  ;  Seho Park  ;  Junghoon Cho  ;  Seung Il Kim  ;  Byeong-Woo Park 
Citation
 International Journal of Clinical Oncology, Vol.19(5) : 842-851, 2014 
Journal Title
 International Journal of Clinical Oncology 
ISSN
 1341-9625 
Issue Date
2014
MeSH
Adult ; Animals ; Biomarkers, Tumor/biosynthesis* ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics* ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Nucleolus/genetics ; Cell Nucleolus/metabolism ; Cytoplasm/genetics ; Cytoplasm/metabolism ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Middle Aged ; Prognosis* ; Proto-Oncogene Proteins c-mdm2/biosynthesis* ; Proto-Oncogene Proteins c-mdm2/genetics ; Receptor, ErbB-2/genetics ; Tissue Array Analysis ; Tumor Suppressor Protein p53/genetics
Keywords
Breast ; Neoplasms ; Proto-oncogene proteins c-mdm2 ; p53 ; Prognosis
Abstract
BACKGROUND: Mouse double minute 2 (Mdm2) is a negative regulator of the tumor suppressor p53. The p53-Mdm2 pathway may play a role in cancer development and prognosis, although the role of p53-Mdm2 in breast cancer remains unclear. METHODS: p53 and Mdm2 expressions were determined by immunohistochemistry of tissue microarrays of 865 breast cancer patients who underwent surgery. Clinicopathological characteristics and survival data were analyzed. Mdm2 expression was categorized into four groups: negative, cytoplasm positive, nucleus positive, and concurrent nuclear and cytoplasm positive (N+&C+). RESULTS: Negative, cytoplasm-positive, nucleus-positive, and N+&C+ expressions of Mdm2 were observed in 59.2, 10.9, 27.8, and 2.1 % of patients, respectively. The N+&C+ group was associated with larger tumor size, higher grade, negativity for estrogen and progesterone receptors, HER2 positivity, high Ki-67 index, p53 positivity, and triple negative breast cancer. p53-positive tumors showed poorer overall survival than p53-negative tumors. The nucleus-positive and N+&C+ groups showed poorer disease-free survival than the negative and cytoplasm-positive groups. In multivariate analysis, nuclear Mdm2 expression including the N+&C+ group was significantly related to poor prognosis. CONCLUSIONS: Concurrent nuclear and cytoplasmic Mdm2 expression was an independent prognostic factor in patients with breast cancer. Subcellular localization of Mdm2 expression should be considered in the evaluation of Mdm2 in breast cancer.
Full Text
http://link.springer.com/article/10.1007%2Fs10147-013-0639-1
DOI
10.1007/s10147-013-0639-1
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Seung Il(김승일)
Park, Byeong Woo(박병우) ORCID logo https://orcid.org/0000-0003-1353-2607
Park, Se Ho(박세호) ORCID logo https://orcid.org/0000-0001-8089-2755
Park, Ji Min(박지민)
Park, Hyung Seok(박형석) ORCID logo https://orcid.org/0000-0001-5322-6036
Cho, Jung Hoon(조정훈)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/100361
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse